Breast implant-associated anaplastic large cell lymphoma is a newly recognized provisional
entity in the 2017 revision of the World Health Organization Classification of Tumors of …

The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be
causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has …

Breast implant–associated anaplastic large cell lymphoma is a malignancy of T lymphocytes
that is associated with the use of textured breast implants in both esthetic and reconstructive …

Since the discovery of the human T-cell leukemia virus-1 (HTLV-1), cellular and animal
models have provided invaluable contributions in the knowledge of viral infection …

Human T-cell leukemia virus type 1 (HTLV-1) is the only identified oncogenic human
retrovirus. HTLV-1 infects approximately 5–10 million people worldwide and is the infectious …

Human T cell leukemia virus type 1 (HTLV-1) was the first retrovirus to be identified as a
causative agent of a cancer in humans. In addition to cancer, adult T-cell leukemia (ATL) …

ABSTRACT NF-κB plays a key role in innate and acquired immunity. Its activity is regulated
through intricate signaling networks. Persistent or excessive activation of NF-κB induces …

The beneficial effects of the polyphenolic compound piceatannol (PC) has been reported for
metabolic diseases, antiproliferative, antioxidant, and anti-cancer properties. Despite its …

Previous studies showed that several members of the S100A family are involved in
neovascularization and tumor development. This study checked whether low concentrations …

Pathologic staging including assessment of margins is essential for the proper management
of patients with breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). As …